The massive share issuance (up to 54%+ current market cap in immediate dilution and potentially 114%+ under the 40M cap) and the shift from a minerals transaction to an unrelated biotech rights purchase raise existential questions about the company's strategic direction. Monitor for shareholder meeting to approve full warrant exercise — which would add up to 9.5M more shares — and any further going-concern updates. The 4.99% beneficial ownership blocker on warrants is temporary and likely to be removed upon shareholder approval.
Price Chart
Executive Summary
Hub Cyber Security (HUBC) issued ~10.1M shares and pre-funded warrants ($15.2M at $1.50/share) to acquire Evofem Biosciences purchase rights with a $4M face amount, and engaged PR Capital as financial advisor for a potential Evofem business combination, while terminating the Ferrox minerals deal. In the context of HUBC's severe financial distress (FY2025 going-concern warning, $1.8M cash, $119.8M net loss), this massively dilutive stock-for-speculative-assets swap signals a desperate survival maneuver with high risk of further value destruction for existing shareholders.
Key Facts
- HUBC purchased $4M face amount of Evofem purchase rights for $15.2M (3.8x face), payable in 590,107 ordinary shares and 9,543,226 pre-funded warrants at $1.50/share
- Total consideration shares capped at 40,000,000 HUBC ordinary shares across this and related Evofem junior note agreements
- PR Capital engaged as non-exclusive financial advisor for Evofem transaction; issued 2,627,118 Advisory Fee Shares (2.5% of Evofem valuation), ~80% subject to forfeiture if transaction fails
- Ferrox Critical Minerals acquisition term sheet terminated by mutual decision
Financial Impact
HUBC issued securities representing ~$19M in value at $1.50/share against a $35M market cap (~54% of market cap), with additional dilution capped at $60M (40M shares). The $15.2M purchase price exceeds HUBC's $1.8M cash balance and implies an Evofem valuation of ~$158M based on the advisory fee calculation.
Risk Factors
- Extreme dilution from up to 40M shares outstanding under the cap, potentially overwhelming the $35M market cap
- Speculative nature of Evofem purchase rights — the underlying (EVFM) is a penny-stock biotech at $0.0154/share exercisable into 259.74M shares
- Going-concern risk from the 20-F qualification combined with a failed strategic move (Ferrox) and a cash balance of $1.8M
- PR Capital's advisory fee structure incentivizes consummating any transaction, not necessarily a value-maximizing one
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-084887 |
| Document: ea029906201ex99-2.htm | 0001213900-26-084887 |
| Document: ea0299062-6k_hubcyber.htm | 0001213900-26-084887 |
| Document: 0001213900-26-084887-index-headers.html | 0001213900-26-084887 |
| Document: 0001213900-26-084887-index.html | 0001213900-26-084887 |
| Document: 0001213900-26-084887.txt | 0001213900-26-084887 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $0.3790 | awaiting T+20 | — | $0.1500 (−60.42%) |
Sep 28, 2026 29d ago | 6-K | $1.49 $0.1500 | ▲ +89.93% | ▲ +89.90% | $0.1500 (+89.93%) |
Aug 4, 2026 11w ago | 6-K | $1.03 | awaiting T+20 | — | $0.1500 (+85.44%) |
Aug 3, 2026 12w ago | 6-K | $26.00 $18.45 | ▼ −29.04% | ▼ −30.28% | $0.1500 (−99.42%) |
Jul 17, 2026 14w ago | 20-F | $1.15 $0.7375 | ▲ +35.87% | ▲ +39.99% | $0.1500 (+86.96%) |
Jul 17, 2026 14w ago | Court Ruling | $1.15 $0.7375 | ▲ +35.87% | ▲ +39.99% | $0.1500 (+86.96%) |
Jul 1, 2026 16w ago | 6-K | $1.49 $1.03 | ▲ +30.87% | ▲ +30.33% | $0.1500 (+89.93%) |
Apr 16, 2026 27w ago | Press Release | $9.15 $0.1470 | ▼ −98.39% | ▼ −104.21% | $0.1500 (−98.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers